SAHAREK JOHN P.

SEC source: 0001641172-25-003111 · ownership.xml · nonDerivative · entry 2

SAHAREK JOHN P. · CIK 0001632091 · CEO & President, ImprimisRx

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 467,388

F1 · shares: The 277,200 shares of Harrow, Inc. ("Harrow") common stock listed in Table I as "Acquired" represent shares upon vesting of performance stock units ("PSUs") granted to Mr. Saharek under Harrow's 2017 Stock Incentive and Awards Plan (the "Incentive Plan") on April 3, 2023. The PSUs vested on April 3, 2025 and were settled in full in shares of Harrow common stock (on a one-for-one basis) on April 7, 2025, following attainment of (i) a two-year service period, and (ii) the achievement of Harrow common stock price targets ranging from $25 - $50. The 109,475 shares of Harrow common stock listed in Table I as "Disposed" were not sold by Mr. Saharek in any market transaction; rather, they were shares of Harrow common stock withheld by the Company for payroll tax purposes from the same aforementioned 277,200 shares pursuant to the terms of the Incentive Plan.

SEC source: 0001641172-25-003111 · ownership.xml · derivative · entry 3

SAHAREK JOHN P. · CIK 0001632091 · CEO & President, ImprimisRx

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 277,200 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The 277,200 shares of Harrow, Inc. ("Harrow") common stock listed in Table I as "Acquired" represent shares upon vesting of performance stock units ("PSUs") granted to Mr. Saharek under Harrow's 2017 Stock Incentive and Awards Plan (the "Incentive Plan") on April 3, 2023. The PSUs vested on April 3, 2025 and were settled in full in shares of Harrow common stock (on a one-for-one basis) on April 7, 2025, following attainment of (i) a two-year service period, and (ii) the achievement of Harrow common stock price targets ranging from $25 - $50. The 109,475 shares of Harrow common stock listed in Table I as "Disposed" were not sold by Mr. Saharek in any market transaction; rather, they were shares of Harrow common stock withheld by the Company for payroll tax purposes from the same aforementioned 277,200 shares pursuant to the terms of the Incentive Plan.

F1 · derivative.exercise_date: The 277,200 shares of Harrow, Inc. ("Harrow") common stock listed in Table I as "Acquired" represent shares upon vesting of performance stock units ("PSUs") granted to Mr. Saharek under Harrow's 2017 Stock Incentive and Awards Plan (the "Incentive Plan") on April 3, 2023. The PSUs vested on April 3, 2025 and were settled in full in shares of Harrow common stock (on a one-for-one basis) on April 7, 2025, following attainment of (i) a two-year service period, and (ii) the achievement of Harrow common stock price targets ranging from $25 - $50. The 109,475 shares of Harrow common stock listed in Table I as "Disposed" were not sold by Mr. Saharek in any market transaction; rather, they were shares of Harrow common stock withheld by the Company for payroll tax purposes from the same aforementioned 277,200 shares pursuant to the terms of the Incentive Plan.

F1 · derivative.expiration_date: The 277,200 shares of Harrow, Inc. ("Harrow") common stock listed in Table I as "Acquired" represent shares upon vesting of performance stock units ("PSUs") granted to Mr. Saharek under Harrow's 2017 Stock Incentive and Awards Plan (the "Incentive Plan") on April 3, 2023. The PSUs vested on April 3, 2025 and were settled in full in shares of Harrow common stock (on a one-for-one basis) on April 7, 2025, following attainment of (i) a two-year service period, and (ii) the achievement of Harrow common stock price targets ranging from $25 - $50. The 109,475 shares of Harrow common stock listed in Table I as "Disposed" were not sold by Mr. Saharek in any market transaction; rather, they were shares of Harrow common stock withheld by the Company for payroll tax purposes from the same aforementioned 277,200 shares pursuant to the terms of the Incentive Plan.

SEC source: 0001641172-25-003111 · ownership.xml · nonDerivative · entry 1

SAHAREK JOHN P. · CIK 0001632091 · CEO & President, ImprimisRx

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 576,863

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The 277,200 shares of Harrow, Inc. ("Harrow") common stock listed in Table I as "Acquired" represent shares upon vesting of performance stock units ("PSUs") granted to Mr. Saharek under Harrow's 2017 Stock Incentive and Awards Plan (the "Incentive Plan") on April 3, 2023. The PSUs vested on April 3, 2025 and were settled in full in shares of Harrow common stock (on a one-for-one basis) on April 7, 2025, following attainment of (i) a two-year service period, and (ii) the achievement of Harrow common stock price targets ranging from $25 - $50. The 109,475 shares of Harrow common stock listed in Table I as "Disposed" were not sold by Mr. Saharek in any market transaction; rather, they were shares of Harrow common stock withheld by the Company for payroll tax purposes from the same aforementioned 277,200 shares pursuant to the terms of the Incentive Plan.

SEC source: 0001493152-24-036244 · ownership.xml · derivative · entry 3

SAHAREK JOHN P. · CIK 0001632091 · CEO of ImprimisRx

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 90,000 shares

Expires 2025-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The stock option was granted on February 1, 2015 under the Issuers 2007 Stock Incentive and Awards Plan and the shares subject to the stock option became exercisable over a 3 year period following its grant date. The stock option had an expiration date of February 1, 2025. 29,107 shares of Harrow common stock listed as disposed were withheld from issuance by Harrow to satisfy Mr. Saharek's payroll tax liability incident and 16,033 shares of Harrow common stock listed as disposed were withheld from issuance by Harrow to satisfy Mr. Saharek's cost to purchase the stock option.

F1 · derivative.exercise_date: The stock option was granted on February 1, 2015 under the Issuers 2007 Stock Incentive and Awards Plan and the shares subject to the stock option became exercisable over a 3 year period following its grant date. The stock option had an expiration date of February 1, 2025. 29,107 shares of Harrow common stock listed as disposed were withheld from issuance by Harrow to satisfy Mr. Saharek's payroll tax liability incident and 16,033 shares of Harrow common stock listed as disposed were withheld from issuance by Harrow to satisfy Mr. Saharek's cost to purchase the stock option.

SEC source: 0001493152-24-036244 · ownership.xml · nonDerivative · entry 2

SAHAREK JOHN P. · CIK 0001632091 · CEO of ImprimisRx

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 299,663

F1 · security: The stock option was granted on February 1, 2015 under the Issuers 2007 Stock Incentive and Awards Plan and the shares subject to the stock option became exercisable over a 3 year period following its grant date. The stock option had an expiration date of February 1, 2025. 29,107 shares of Harrow common stock listed as disposed were withheld from issuance by Harrow to satisfy Mr. Saharek's payroll tax liability incident and 16,033 shares of Harrow common stock listed as disposed were withheld from issuance by Harrow to satisfy Mr. Saharek's cost to purchase the stock option.

SEC source: 0001493152-24-036244 · ownership.xml · nonDerivative · entry 1

SAHAREK JOHN P. · CIK 0001632091 · CEO of ImprimisRx

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 344,803

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001493152-24-008930 · ownership.xml · derivative · entry 2

SAHAREK JOHN P. · CIK 0001632091 · CEO of ImprimisRx

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2024-03-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The stock option was granted on March 3, 2014 under the Issuers 2007 Stock Incentive and Awards Plan and the shares subject to the stock option became exercisable over a 3 year period following its grant date. The stock option had an expiration date of March 3, 2024.

F1 · derivative.exercise_date: The stock option was granted on March 3, 2014 under the Issuers 2007 Stock Incentive and Awards Plan and the shares subject to the stock option became exercisable over a 3 year period following its grant date. The stock option had an expiration date of March 3, 2024.

SEC source: 0001493152-24-008930 · ownership.xml · nonDerivative · entry 1

SAHAREK JOHN P. · CIK 0001632091 · CEO of ImprimisRx

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 254,803

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The stock option was granted on March 3, 2014 under the Issuers 2007 Stock Incentive and Awards Plan and the shares subject to the stock option became exercisable over a 3 year period following its grant date. The stock option had an expiration date of March 3, 2024.

SEC source: 0001493152-24-007456 · ownership.xml · derivative · entry 3

SAHAREK JOHN P. · CIK 0001632091 · CEO of ImprimisRx

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The listed acquired 30,000 shares of Harrow, Inc. ("Harrow")_common stock represent restricted stock units (RSUs") granted to Mr. Saharek on February 19, 2021 under the Issuer's 2017 Stock Incentive and Awards Plan, as amended. The RSUs vested after a three-year period following the award date. 12,616 shares of Harrow common stock listed as disposed were withheld from issuance by Harrow to satisfy Mr. Saharek's payroll tax liability incident related to the vesting of the RSUs. Such withholding did not involve any market sales or other market transactions.

F1 · derivative.exercise_date: The listed acquired 30,000 shares of Harrow, Inc. ("Harrow")_common stock represent restricted stock units (RSUs") granted to Mr. Saharek on February 19, 2021 under the Issuer's 2017 Stock Incentive and Awards Plan, as amended. The RSUs vested after a three-year period following the award date. 12,616 shares of Harrow common stock listed as disposed were withheld from issuance by Harrow to satisfy Mr. Saharek's payroll tax liability incident related to the vesting of the RSUs. Such withholding did not involve any market sales or other market transactions.

F1 · derivative.expiration_date: The listed acquired 30,000 shares of Harrow, Inc. ("Harrow")_common stock represent restricted stock units (RSUs") granted to Mr. Saharek on February 19, 2021 under the Issuer's 2017 Stock Incentive and Awards Plan, as amended. The RSUs vested after a three-year period following the award date. 12,616 shares of Harrow common stock listed as disposed were withheld from issuance by Harrow to satisfy Mr. Saharek's payroll tax liability incident related to the vesting of the RSUs. Such withholding did not involve any market sales or other market transactions.

SEC source: 0001493152-24-007456 · ownership.xml · nonDerivative · entry 2

SAHAREK JOHN P. · CIK 0001632091 · CEO of ImprimisRx

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 249,803

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The listed acquired 30,000 shares of Harrow, Inc. ("Harrow")_common stock represent restricted stock units (RSUs") granted to Mr. Saharek on February 19, 2021 under the Issuer's 2017 Stock Incentive and Awards Plan, as amended. The RSUs vested after a three-year period following the award date. 12,616 shares of Harrow common stock listed as disposed were withheld from issuance by Harrow to satisfy Mr. Saharek's payroll tax liability incident related to the vesting of the RSUs. Such withholding did not involve any market sales or other market transactions.

SEC source: 0001493152-24-007456 · ownership.xml · nonDerivative · entry 1

SAHAREK JOHN P. · CIK 0001632091 · CEO of ImprimisRx

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 262,419

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001493152-23-041355 · ownership.xml · derivative · entry 3

SAHAREK JOHN P. · CIK 0001632091 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires 2023-11-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: The stock option was granted on November 12, 2013 under the Issuers 2007 Stock Incentive and Awards Plan and the shares subject to the stock option became exercisable over a 3 year period following its grant date. The stock option had an expiration date of November 12, 2023.

F1 · derivative.exercise_date: Shares withheld to satisfy the exercise price and tax liability incident to the exercise of the stock option. Such withholding did not involve any market sales or other market transactions.

SEC source: 0001493152-23-041355 · ownership.xml · nonDerivative · entry 2

SAHAREK JOHN P. · CIK 0001632091 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 232,419

F1 · security: Shares withheld to satisfy the exercise price and tax liability incident to the exercise of the stock option. Such withholding did not involve any market sales or other market transactions.

SEC source: 0001493152-23-041355 · ownership.xml · nonDerivative · entry 1

SAHAREK JOHN P. · CIK 0001632091 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 242,197

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Shares withheld to satisfy the exercise price and tax liability incident to the exercise of the stock option. Such withholding did not involve any market sales or other market transactions.

F1 · price: Shares withheld to satisfy the exercise price and tax liability incident to the exercise of the stock option. Such withholding did not involve any market sales or other market transactions.

SEC source: 0001493152-23-025148 · ownership.xml · derivative · entry 3

SAHAREK JOHN P. · CIK 0001632091 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 277,200 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The 277,200 shares of Harrow Health, Inc. ("Harrow") common stock listed in Table I as "Acquired" represent shares issued based on vesting of performance stock units ("PSUs") granted to Mr. Saharek under Harrow's 2017 Stock Incentive and Awards Plan (the "Incentive Plan") on July 23, 2021. The PSUs were settled in full (on a one-for-one basis) on July 18, 2023, following attainment of total stockholder return targets ranging from 50% - 175 % following the date of the award. The 109,080 shares of Harrow common stock listed in Table I as "Disposed" were not sold by Mr. Saharek in any transaction; rather, they were shares of Harrow common stock withheld by the Company for payroll tax purposes from the same aforementioned 277,200 shares pursuant to the terms of the Incentive Plan.

F1 · derivative.exercise_date: The 277,200 shares of Harrow Health, Inc. ("Harrow") common stock listed in Table I as "Acquired" represent shares issued based on vesting of performance stock units ("PSUs") granted to Mr. Saharek under Harrow's 2017 Stock Incentive and Awards Plan (the "Incentive Plan") on July 23, 2021. The PSUs were settled in full (on a one-for-one basis) on July 18, 2023, following attainment of total stockholder return targets ranging from 50% - 175 % following the date of the award. The 109,080 shares of Harrow common stock listed in Table I as "Disposed" were not sold by Mr. Saharek in any transaction; rather, they were shares of Harrow common stock withheld by the Company for payroll tax purposes from the same aforementioned 277,200 shares pursuant to the terms of the Incentive Plan.

F1 · derivative.expiration_date: The 277,200 shares of Harrow Health, Inc. ("Harrow") common stock listed in Table I as "Acquired" represent shares issued based on vesting of performance stock units ("PSUs") granted to Mr. Saharek under Harrow's 2017 Stock Incentive and Awards Plan (the "Incentive Plan") on July 23, 2021. The PSUs were settled in full (on a one-for-one basis) on July 18, 2023, following attainment of total stockholder return targets ranging from 50% - 175 % following the date of the award. The 109,080 shares of Harrow common stock listed in Table I as "Disposed" were not sold by Mr. Saharek in any transaction; rather, they were shares of Harrow common stock withheld by the Company for payroll tax purposes from the same aforementioned 277,200 shares pursuant to the terms of the Incentive Plan.

SEC source: 0001493152-23-025148 · ownership.xml · nonDerivative · entry 2

SAHAREK JOHN P. · CIK 0001632091 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 222,197

F1 · shares: The 277,200 shares of Harrow Health, Inc. ("Harrow") common stock listed in Table I as "Acquired" represent shares issued based on vesting of performance stock units ("PSUs") granted to Mr. Saharek under Harrow's 2017 Stock Incentive and Awards Plan (the "Incentive Plan") on July 23, 2021. The PSUs were settled in full (on a one-for-one basis) on July 18, 2023, following attainment of total stockholder return targets ranging from 50% - 175 % following the date of the award. The 109,080 shares of Harrow common stock listed in Table I as "Disposed" were not sold by Mr. Saharek in any transaction; rather, they were shares of Harrow common stock withheld by the Company for payroll tax purposes from the same aforementioned 277,200 shares pursuant to the terms of the Incentive Plan.

SEC source: 0001493152-23-025148 · ownership.xml · nonDerivative · entry 1

SAHAREK JOHN P. · CIK 0001632091 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 331,277

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The 277,200 shares of Harrow Health, Inc. ("Harrow") common stock listed in Table I as "Acquired" represent shares issued based on vesting of performance stock units ("PSUs") granted to Mr. Saharek under Harrow's 2017 Stock Incentive and Awards Plan (the "Incentive Plan") on July 23, 2021. The PSUs were settled in full (on a one-for-one basis) on July 18, 2023, following attainment of total stockholder return targets ranging from 50% - 175 % following the date of the award. The 109,080 shares of Harrow common stock listed in Table I as "Disposed" were not sold by Mr. Saharek in any transaction; rather, they were shares of Harrow common stock withheld by the Company for payroll tax purposes from the same aforementioned 277,200 shares pursuant to the terms of the Incentive Plan.

SEC source: 0001493152-23-010884 · ownership.xml · derivative · entry 1

SAHAREK JOHN P. · CIK 0001632091 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 277,200

Underlying: Common Stock · 277,200 shares

Expires 2028-04-03

F1 · derivative.exercise_price: Represents performance-based restricted stock units ("PSUs") granted under the Issuer's 2017 Stock Incentive and Awards Plan, as amended (the "Plan"). Each PSU represents a contingent right to receive one share of common stock of the Issuer upon vesting. The vesting of the PSUs (granted in lieu of service only stock option and restricted stock unit awards) require (i) a minimum of a two-year service period, and (ii) the achievement and maintenance of Harrow common stock price targets of $25 (causing the vesting of 39,600 PSU shares), $35 (causing the vesting of 59,400 PSU shares), $45 (causing the vesting of 79,200 PSU shares), $50 (causing the vesting of 99,000 PSU shares).

F1 · derivative.exercise_date: Represents performance-based restricted stock units ("PSUs") granted under the Issuer's 2017 Stock Incentive and Awards Plan, as amended (the "Plan"). Each PSU represents a contingent right to receive one share of common stock of the Issuer upon vesting. The vesting of the PSUs (granted in lieu of service only stock option and restricted stock unit awards) require (i) a minimum of a two-year service period, and (ii) the achievement and maintenance of Harrow common stock price targets of $25 (causing the vesting of 39,600 PSU shares), $35 (causing the vesting of 59,400 PSU shares), $45 (causing the vesting of 79,200 PSU shares), $50 (causing the vesting of 99,000 PSU shares).

SEC source: 0001493152-22-005270 · ownership.xml · derivative · entry 3

SAHAREK JOHN P. · CIK 0001632091 · President, ImprimisRx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 50,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents restricted stock units ("RSUs") granted to Mr. Saharek under the Issuer's 2017 Stock Incentive and Awards Plan on February 19, 2019. The RSUs settled in one share of common stock for each RSU and vested in full on February 19, 2022, the third anniversary of the grant date. 25,923 shares of common stock were withheld from issuance to Mr. Saharek for payroll tax purposes.

F1 · derivative.exercise_date: Represents restricted stock units ("RSUs") granted to Mr. Saharek under the Issuer's 2017 Stock Incentive and Awards Plan on February 19, 2019. The RSUs settled in one share of common stock for each RSU and vested in full on February 19, 2022, the third anniversary of the grant date. 25,923 shares of common stock were withheld from issuance to Mr. Saharek for payroll tax purposes.

F1 · derivative.expiration_date: Represents restricted stock units ("RSUs") granted to Mr. Saharek under the Issuer's 2017 Stock Incentive and Awards Plan on February 19, 2019. The RSUs settled in one share of common stock for each RSU and vested in full on February 19, 2022, the third anniversary of the grant date. 25,923 shares of common stock were withheld from issuance to Mr. Saharek for payroll tax purposes.

SEC source: 0001493152-22-005270 · ownership.xml · nonDerivative · entry 2

SAHAREK JOHN P. · CIK 0001632091 · President, ImprimisRx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,077

F1 · security: Represents restricted stock units ("RSUs") granted to Mr. Saharek under the Issuer's 2017 Stock Incentive and Awards Plan on February 19, 2019. The RSUs settled in one share of common stock for each RSU and vested in full on February 19, 2022, the third anniversary of the grant date. 25,923 shares of common stock were withheld from issuance to Mr. Saharek for payroll tax purposes.

SEC source: 0001493152-22-005270 · ownership.xml · nonDerivative · entry 1

SAHAREK JOHN P. · CIK 0001632091 · President, ImprimisRx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents restricted stock units ("RSUs") granted to Mr. Saharek under the Issuer's 2017 Stock Incentive and Awards Plan on February 19, 2019. The RSUs settled in one share of common stock for each RSU and vested in full on February 19, 2022, the third anniversary of the grant date. 25,923 shares of common stock were withheld from issuance to Mr. Saharek for payroll tax purposes.

F1 · price: Represents restricted stock units ("RSUs") granted to Mr. Saharek under the Issuer's 2017 Stock Incentive and Awards Plan on February 19, 2019. The RSUs settled in one share of common stock for each RSU and vested in full on February 19, 2022, the third anniversary of the grant date. 25,923 shares of common stock were withheld from issuance to Mr. Saharek for payroll tax purposes.

SEC source: 0001493152-21-017682 · ownership.xml · derivative · entry 1

SAHAREK JOHN P. · CIK 0001632091 · President, ImprimisRx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 277,200

Underlying: Common Stock · 277,200 shares

Expires 2026-07-23

F1 · security: Represents performance-based restricted stock units ("PSUs") granted under the Issuer's 2017 Stock Incentive and Awards Plan, as amended (the "Plan"). Each PSU represents a contingent right to receive one share of common stock of the Issuer upon vesting. Vesting of the PSUs requires a minimum of a two-year service period and achievement of pre-determined total stockholder return-based performance targets ranging from a 50% - 250% increase during the term of the PSUs.

F1 · derivative.exercise_price: Represents performance-based restricted stock units ("PSUs") granted under the Issuer's 2017 Stock Incentive and Awards Plan, as amended (the "Plan"). Each PSU represents a contingent right to receive one share of common stock of the Issuer upon vesting. Vesting of the PSUs requires a minimum of a two-year service period and achievement of pre-determined total stockholder return-based performance targets ranging from a 50% - 250% increase during the term of the PSUs.

F1 · derivative.exercise_date: Represents performance-based restricted stock units ("PSUs") granted under the Issuer's 2017 Stock Incentive and Awards Plan, as amended (the "Plan"). Each PSU represents a contingent right to receive one share of common stock of the Issuer upon vesting. Vesting of the PSUs requires a minimum of a two-year service period and achievement of pre-determined total stockholder return-based performance targets ranging from a 50% - 250% increase during the term of the PSUs.

SEC source: 0001493152-21-004656 · ownership.xml · derivative · entry 1

SAHAREK JOHN P. · CIK 0001632091 · President, ImprimisRx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2024-02-19

F1 · derivative.exercise_date: Represents restricted stock units ("RSUs") granted under the Issuer's 2017 Stock Incentive and Awards Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer upon the vesting and settlement of the RSU. The RSUs vest and settle in full on the third anniversary of the date of grant.

SEC source: 0001493152-19-002377 · ownership.xml · derivative · entry 2

SAHAREK JOHN P. · CIK 0001632091 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2022-02-19

F2 · derivative.exercise_date: Represents restricted stock units ("RSUs") granted under the Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer upon the vesting and settlement of the RSU. The RSUs vest and settle in full on the third anniversary of the date of grant.

SEC source: 0001493152-19-002377 · ownership.xml · derivative · entry 1

SAHAREK JOHN P. · CIK 0001632091 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2029-02-19

F1 · derivative.exercise_date: Represents stock options granted under the Issuer's 2017 Stock Incentive and Awards Plan (the "Plan"). The stock options vest in equal quarterly installments over a three-year period.

SEC source: 0001493152-18-001437 · form4.xml · derivative · entry 2

SAHAREK JOHN P. · CIK 0001632091 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: On February 1, 2018, restricted stock units ("RSUs") granted to Mr. Saharek on February 1, 2015 vested, and 30,000 shares of common stock were issued to him. Payroll withholding taxes related to the vested RSUs and share issuance were paid by Mr. Saharek.

F1 · derivative.exercise_date: On February 1, 2018, restricted stock units ("RSUs") granted to Mr. Saharek on February 1, 2015 vested, and 30,000 shares of common stock were issued to him. Payroll withholding taxes related to the vested RSUs and share issuance were paid by Mr. Saharek.

F1 · derivative.expiration_date: On February 1, 2018, restricted stock units ("RSUs") granted to Mr. Saharek on February 1, 2015 vested, and 30,000 shares of common stock were issued to him. Payroll withholding taxes related to the vested RSUs and share issuance were paid by Mr. Saharek.

SEC source: 0001493152-18-001437 · form4.xml · nonDerivative · entry 1

SAHAREK JOHN P. · CIK 0001632091 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: On February 1, 2018, restricted stock units ("RSUs") granted to Mr. Saharek on February 1, 2015 vested, and 30,000 shares of common stock were issued to him. Payroll withholding taxes related to the vested RSUs and share issuance were paid by Mr. Saharek.

SEC source: 0001493152-18-000186 · form4.xml · derivative · entry 1

SAHAREK JOHN P. · CIK 0001632091 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2028-01-02

F1 · derivative.exercise_date: Represents stock options granted under the Issuer's 2017 Stock Incentive and Awards Plan. The stock options vest in equal quarterly installments over a three year period.

SEC source: 0001493152-17-001109 · form4.xml · derivative · entry 1

SAHAREK JOHN P. · CIK 0001632091 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Common Stock · 55,000 shares

Expires 2027-02-01

F1 · derivative.exercise_date: Represents stock options granted under the Issuer's 2007 Stock Incentive and Awards Plan. The stock options vest in equal quarterly installments over a three year period.